作者: Mary-Louise Rogers , Robert Archer Rush
DOI: 10.1016/J.JCONREL.2011.08.026
关键词:
摘要: Non-viral gene therapy systems are considered safer than viral delivery. This article reviews recent research describing novel, non-viral delivery to the central nervous system, with a special emphasis on receptor mediated using antibodies (termed immunogenes) specific receptors. By targeting agents such as that can be retrogradely transported within neurons, therapies deliver genes neurons protected by blood brain barrier. Components of effective described including DNA/RNA carriers, receptor-mediated endocytosis, endosomal escape and nuclear entry. In addition, stealth polyethylene glycol used improve in-vivo discussed. The value immunogenes therapeutic for fatal diseases Amyotrophic Lateral Sclerosis is significant but further work confirm efficacy required before truly achieved.